Buy NOVORAPID 100IU VIAL (INSULIN) Online

Overview: NovoRapid 100IU Vial is a rapid-acting insulin analog manufactured by Novo Nordisk, designed to provide effective glycemic control for individuals with diabetes mellitus. This insulin formulation is characterized by its rapid onset of action, allowing for precise mealtime dosing to manage postprandial glucose levels efficiently.

Key Features:

1. Rapid Onset and Short Duration: NovoRapid contains insulin aspart, a rapid-acting insulin analog that starts working within 10-20 minutes after injection. It peaks within 1-3 hours and has a duration of action lasting up to 3-5 hours, helping to mimic the body’s natural insulin response to meals.
2. Vial Format: Each NovoRapid 100IU vial contains 10 mL of insulin, providing multiple doses for flexible insulin therapy management. The vial format is suitable for patients requiring varying insulin doses and allows for precise withdrawal of the required amount using insulin syringes or insulin pens.
3. Clinical Efficacy: NovoRapid is clinically proven to effectively reduce postprandial glucose excursions when administered before or immediately after meals. This helps in achieving target blood glucose levels and reducing the risk of hyperglycemia following meals.
4. Versatile Administration: It can be administered via subcutaneous injection using insulin syringes or through insulin pumps for individuals who require continuous insulin infusion. This versatility makes it adaptable to different treatment regimens and patient needs.

Indications: NovoRapid 100IU vial is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and above who require insulin for the maintenance of blood glucose levels.

Usage Instructions:

• Dosage: The dosage of NovoRapid should be individualized based on the patient’s metabolic needs, carbohydrate intake, blood glucose monitoring, and healthcare provider recommendations.
• Administration: Administer subcutaneously, typically 5-10 minutes before a meal or immediately after a meal, to control postprandial glucose levels effectively.
• Storage: Store below 30°C (86°F). Once in use, the vial should be kept at room temperature (below 30°C) for up to 6 weeks or in the refrigerator (2°C to 8°C) for up to 4 weeks. Avoid freezing to maintain potency.

Precautions:

• Patients should be educated on proper injection technique and rotation of injection sites to minimize the risk of lipodystrophy or localized cutaneous amyloidosis.
• Hypoglycemia is a potential risk, especially if the insulin dose is too high relative to the patient’s carbohydrate intake or physical activity level. Regular blood glucose monitoring and adjustment of insulin doses are essential.

Contraindications:

• NovoRapid 100IU vial is contraindicated in patients with hypersensitivity to insulin aspart or any of the excipients.

Conclusion: NovoRapid 100IU Vial by Novo Nordisk offers a reliable solution for managing postprandial glucose levels in patients with diabetes mellitus. With its rapid onset, short duration of action, and versatile administration options, it provides flexibility and precision in insulin therapy. Designed to meet the diverse needs of patients and healthcare professionals, NovoRapid stands as a testament to Novo Nordisk’s commitment to innovation and quality in diabetes care.

For comprehensive prescribing information and safety considerations, refer to the product labeling or consult with a healthcare professional.